Breakthrough & Experimental Cancer Treatments (2024–2025)

Under development

This page is a placeholder under scientific review. Do not treat it as a complete or clinically validated summary until it is expanded with primary references.

Note: Information reflects 2025 standards. This page summarizes cutting‑edge therapies with references; see linked subpages for details.

Oncolytic Virus Therapy

• Mechanisms; approved agents (T‑VEC); key combinations (virus+ICI, virus+CAR‑T)

Quantum Biology Applications

• Bio‑nanoantennae concepts; quantum tunneling/coherence hypotheses; early translational work

Magnetic Hyperthermia

• Nanoparticle platforms; clinical targets (glioblastoma, pancreas); combinations

Photodynamic Therapy (PDT)

• 3rd‑gen photosensitizers; NIR activation; PDT+IO combinations

CAR‑T Innovations

• In vivo CAR‑T; off‑the‑shelf; solid tumor targets

Nanotechnology Drug Delivery

• Stimuli‑responsive/theragnostic carriers; AI‑optimized design

Emerging Modalities

• Acoustic therapy; TTFields; cryo+IO; synthetic biology; metabolic reprogramming

Clinical Trial Landscape (2024–2025)

• Snapshot of active trials and leading indications

Future Directions & Challenges

• Integration, manufacturing, regulatory, equity